Characterization and quantification of major constituents of Xue Fu Zhu Yu by UPLC-DAD-MS/MS

Journal of Pharmaceutical and Biomedical Analysis

Volumn 62, Issue , 2012, Pages 203-209

  Zhang, Lei ^a   Zhu, Lin ^a   Wang, Yuefei ^a   Jiang, Zhenzuo ^a   Chai, Xin ^a   Zhu, Yan ^a   Gao, Xiumei ^a   Qi, Aidi ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Qualitative analysis; Quantitative analysis; UPLC DAD; UPLC MS; Xue Fu Zhu Yu

Indexed keywords

5 HYDROXYMETHYLFURFURAL; ALBIFLORIN; AMYGDALIN; AURANTIIN; CHINESE DRUG; FERULIC ACID; GLYCYRRHIZIC ACID; HYDROXYSAFFLOR YELLOW A; ISOLIQUIRITIGENIN; KAEMPFEROL; LICOCHALCONE A; LIQUIRITIN; NEOHESPERIDIN; PAEONIFLORIN; RUTOSIDE; SAIKOSAPONIN A; UNCLASSIFIED DRUG;

ARTICLE; BUPLEURUM CHINENSE; MEDICINAL PLANT; PLATYCODON GRANDIFLORUM; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, LIQUID; DRUGS, CHINESE HERBAL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84862799373     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.12.026     Document Type: Article

References (21)

1. National Commission of Chinese Pharmacopoeia Pharmacopoeia of the People's Republic of China 2010, vol. 1. China Medical Science and Technology Press, Beijing, p. 693.
2. Li Y., Chen K., Shi Z. Effect of xuefu zhuyu pill on blood stasis syndrome and risk factor of atherosclerosis. Chin. J. Integr. Med. 1998, 18:71-73.
3. Yu D.Y., Wei K.B., Wo X.D. Clinical and experimental study of xuefu zhuyu tang in treating qi stagnation and the blood stasis type of hyperlipidemia. Chin. J. Integr. Tradit. West. Med. 1988, 8:601-603. 582.
4. Shi D.Z. A survey of clinical use and research of xuefu zhuyu decoction. Chin. J. Integr. Med. 1992, 12:447-448.
5. Tang D., Liu Z., Zhang H., Sun M., Sui Y. Protective effects of xuefu zhuyu decoction on myocardium ischemia reperfusion injury in rats. China J. Chin. Mater. Med. 2010, 35:3077-3079.
6. Lei Y., Chen K.J., Li Z.W. Study on relationship of clinical effect of xuefu zhuyu concentrated pill and serum pharmacological anti-platelet activating effect in vitro. Chin. J. Integr. Med. 2002, 22:270-273.
7. Su B., Sun Q., Li X.L. Pharmacological studies and clinical application of Xue Fu Zhu Yu decoction. Chin. Tradit. Patent Med. 2002, 24:965-967.
8. Yan Y.D., Jin Y., Zhou Z.G. Determination of content of oleanolic acid of Xue Fu Zhu Yu wan by TLC scanning. Chin. Hosp. Pharm. J. 2001, 21:719-721.
9. Shen Y.X., Yang H.H., Tan F., Luo G.A. Kernel Isomap Numbers-PLS modeling method and application in oral liquid extraction process of NIR spectra. Chin. Tradit. Patent Med. 2010, 32:831-833.
10. Li D., Zuo J.L. FAAS determination of trace elements in Xuefuzhuyu pills. Chin. J. Pharm. Anal. 2009, 29:150-152.
11. Gao Y., Gao W.Y., Dong X. LC-ELSD analysis for simultaneous determination of five components in the Xue Fu Zhu Yu capsules. Front. Chem. Eng. China 2010, 4:96-101.
12. Yan Y., Yang H.M., Wei H.Z. Simultaneous determination of 5 components in Xue Fu Zhu Yu oral liquid by HPLC under different UV-vis waves. Chin. J. Pharm. Anal. 2009, 29:347-350.
13. Liu Z.H., Ye T.X., Zhao L.L., Chen Y. Simultaneous determination of multicomponent in Xue Fu Zhu Yu granule with different UV-wavelength by HPLC. China J. Chin. Mater. Med. 2010, 35:2157-2160.
14. Gao Y., Gao W.Y. Simultaneous determination of nine active components in traditional Chinese medicine 'Xue-Fu-Zhu-Yu' capsule by HPLC-ELSD. Lat. Am. J. Pharm. 2011, 30:281-288.
15. Luan L.J., Hu L., Qiu G.L., Cheng Y.Y. Identification of constituents of Xue Fu Zhu Yu tang in rabbit body fluids by liquid chromatography-electro-spray mass spectrometry. Chin. Pharm. J. 2006, 41:1252-1255.
16. Zhang H.J., Cheng Y.Y. An HPLC/MS method for identifying major constituents in the hypocholesterolemic extracts of Chinese medicine formula Xue Fu Zhu Yu decoction. Biomed. Chromatogr. 2006, 20:821-826.
17. Zhang H.J., Cheng Y.Y., Liu L. Phytochemical analysis of anti-atherogenic constituents of Xue Fu Zhu Yu Tang using HPLC-DAD-ESI-MS. Chem. Pharm. Bull. 2004, 52:1295-1301.
18. Sun M.Q., Lu J.Q., Zhang H.G. Analysis of constituents of Xue Fu Zhu Yu tang using LC-MS spectrometry technology. Chin. Tradit. Patent Med. 2009, 31:793-794.
19. Liang S.P., Liu F., Guo M.L. A new method for determination of kaempfero-3-O-rutinoside in plasma: application to pharmacokinetic study in Sprague-Dawley rats. Chin. J. Clin. Pharmacol. Ther. 2006, 11:491-496.
20. Ni S.M., Qian D.W. Analysis of chemical composition of Dachuanxiong Fang by ultra performance liquid chromatography electrospray ionization quadrupole time of flight/mass spectrometry. Chin. J. Exp. Tradit. Med. Formulae 2010, 16:39-45.
21. Liang H., Zhao Y.Y., Lu X.H. Isolation and identification of the ligustilide compounds from the Root of Angelica sinensis. China J. Chin. Mater. Med. 2003, 28:423-425.